NEUROGAMI MEDICAL, INC.

Neurogami Medical, Inc. is a Mountain View, California-based medical device company developing novel neurovascular treatments for intracranial aneurysms. The company's lead program focuses on an intra-aneurysmal rapid occlusion device designed to improve aneurysm healing outcomes over existing treatments such as coiling and flow diverters. Neurogami Medical has received NIH SBIR/STTR funding (including an R43 Phase I and subsequent Phase II awards totaling nearly .5 million) from the National Institute of Neurological Disorders and Stroke, and has been co-founded by Stephen Hebert and Bart Bojanowski. The company's technology has been referenced in peer-reviewed neurosurgery and neurology research publications.